Menú

ISAC
ISAC (Intervencions Sanitàries i Activitats Comunitàries)

Group leader
avatar_investigadors.jpg
Francisco Martín Luján
avatar_grups_recerca.png

Publications

Cohort Event Monitoring of COVID-19 Vaccine Safety Using Patient-Reported Outcomes in Lactating Women

E. MAISONNEUVE, F. CICCIMARRA, N. LUXI, C. BELLITTO, M. RAETHKE, F. VAN HUNSEL, T. LIEBER, E. MULDER, F. RIEFOLO, F. VILLALOBOS, N. THURIN, F. MARQUES, K. MORTON, F. O'SHAUGHNESSY, S. SONDERLICHOVÁ, A. FARCAS, J. GIELE-ESHUIS, S. SIISKONEN, D. BAUD, M. STURKENBOOM, A. PANCHAUD and G. TRIFIRÒ
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
Interim Results from the VAC4EU Post-Authorization Safety Study (PASS) Among Recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) Vaccine in Europe

D. WEIBEL, C. DE LUISE, A. ROYO, O. RYAN, T. VAZ, J. AGUADO, J. MARSAL, X. MARTINEZ, R. WEINRIB, N. YEFIMENKO, E. PALÀ, B. POBLADOR-PLOU, A. GIMENO-MIGUEL, A. SANTOS-MEJÍAS, E. MARCONI, E. BARBIERI, L. STONA, T. LYSEN, D. ROY, G. HYERACI, A. GIRARDI, A. LUPATTELLI, A. DESALEGN, F. VILLALOBOS, C. BISSACCO, K. KENDRICK, R. GARG, H. RUBINO, M. STURKENBOOM and A. ARANA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
Cohort Event Monitoring of COVID-19 Vaccine Safety Using Patient-Reported Outcomes in Pregnant Women

E. MAISONNEUVE, F. CICCIMARRA, N. LUXI, C. BELLITTO, M. RAETHKE, F. VAN HUNSEL, T. LIEBER, E. MULDER, F. RIEFOLO, F. VILLALOBOS, N. THURIN, F. MARQUES, K. MORTON, F. O'SHAUGHNESSY, S. SONDERLICHOVÁ, A. FARCAS, S. SIISKONEN, D. BAUD, J. GIELE-ESHUIS, M. STURKENBOOM, G. TRIFIRÒ and A. PANCHAUD
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
Impact of Data Source Diversity on the Distribution of Key Variables in Pregnancy Cohorts Based on the ConcePTION Pregnancy Algorithm Leveraging a Random Forest Imputation Model

A. GIRARDI, G. LIMONCELLA, G. HYERACI, G. ROBERTO, C. BARTOLINI, O. PAOLETTI, D. MESSINA, F. VILLALOBOS, C. BISSACCO, J. VAN DEN BERG, E. HOUBEN, K. SANTACÀ, V. IENTILE, Y. INGRASCIOTTA, G. TRIFIRÒ, V. HOXHAJ, C. DURÁN, J. RIERA-ARNAU, P. GARCIA, M. MARTÍN-PÉREZ, C. HUERTA-ALVAREZ, A. LLORENTE-GARCIA, F. SÁNCHEZ-SÁEZ, G. SANFÉLIX-GIMENO, C. RODRÍGUEZ-BERNAL, R. LASSALLE, J. JOVÉ, M. BERNARD, N. THURIN, S. JORDAN, D. THAYER, H. EVANS, A. COLDEA, M. MANFRINI, M. VAN GELDER, S. HAYATI, T. SCHINK, M. TARI, R. PAJOUHESHNIA, A. AFONSO, M. LE NOAN-LAINÉ, D. MOLGAARD-NIELSEN, M. CUNNINGTON, C. DODD, M. STURKENBOOM, H. NORDENG and R. GINI
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study.

Bellitto C, Luxi N, Ciccimarra F, L'Abbate L, Raethke M, van Hunsel F, Lieber T, Mulder E, Riefolo F, Villalobos F, Thurin NH, Marques FB, Morton K, O'Shaughnessy F, Sonderlichová S, Farcas A, Janneke GE, Sturkenboom MC and Trifirò G
DRUG SAFETY. 2024 Oct 1; . doi:10.1007/s40264-024-01449-x; PMID:38907947

See more: